{'text': 'Pfizer says it could be leader in cancer with many new drugs', 'publisher': {'href': 'https://medicalxpress.com', 'title': 'Medical Xpress'}, 'created_at': 'Tue, 22 Sep 2015 07:00:00 GMT', 'description': 'Pfizer says it could be leader in cancer with many new drugs  Medical Xpress', 'url': 'https://news.google.com/rss/articles/CBMiekFVX3lxTE1qNmFwUUdJWlFkY3V6LURTY2RTeUJyU2dwR01zVVNSR19UeGR2ZktSUkNmYlhfb3BNYkpDTkpYWEQ3eUlTY0ViQ3ZyX012MksxNXY0V3pmY2JScXktSkVlc2RUWWtOV2lVV0N1empUVXZHaFVjSmhQN1JB?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': "Zoetis makes top 10 in '100 Best Companies for Working Mothers'", 'publisher': {'href': 'https://www.mlive.com', 'title': 'MLive.com'}, 'created_at': 'Tue, 22 Sep 2015 07:00:00 GMT', 'description': "Zoetis makes top 10 in '100 Best Companies for Working Mothers'  MLive.com", 'url': 'https://news.google.com/rss/articles/CBMikgFBVV95cUxNaWZ6MFQxaV84QjJ6MXFHeWFEeGFuSlJBTEFLWHB2ZFU2dTRnSk1aYmJkdTQtaEZHMlg2bEpzWFJyLU9iS3pqckt4YlhlZi0tU05rZ29ZdXZFTnVCSUNIcVpwN3psMzFqSVhSM041UUJ5NEpxLWNtOFJ0eFNKQXhYdzY4dTVOa1MzV0RsVjNOTjhKQQ?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Report: Justice Dept. Names Chen to Controversial Compliance Counsel Post', 'publisher': {'href': 'https://www.law.com', 'title': 'Law.com'}, 'created_at': 'Mon, 21 Sep 2015 07:00:00 GMT', 'description': 'Report: Justice Dept. Names Chen to Controversial Compliance Counsel Post  Law.com', 'url': 'https://news.google.com/rss/articles/CBMiYkFVX3lxTE9oc0hIYmFpNXZUeVp3QWIzTU5PWWFfLTF2SGxsX21qaG1odmhzZThWWFJmQXUzcktic3dIM0pONlI0SklrMDR5MkdzTlVkQXVTVU9XVVpNV2F3ODktQURvdURR?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Apple tops stock-buyback list even as repurchases shrink', 'publisher': {'href': 'https://www.marketwatch.com', 'title': 'MarketWatch'}, 'created_at': 'Mon, 21 Sep 2015 07:00:00 GMT', 'description': 'Apple tops stock-buyback list even as repurchases shrink  MarketWatch', 'url': 'https://news.google.com/rss/articles/CBMiowFBVV95cUxQTjRfU0MySjkyMnQtbS1PZGUzcHdXanBjcEZDYnpaM09jNUN4YzJadm9qQWhfOGdpOEMybW1nZ3dnbG1pa1BUaFdudTFvQzg5SkNwU3FYZ2FWQUpyb3hONG41TEIwV1hCWDduRk82MlBCb2VpdFNkLXI3NEEzU0ZKSHFnVUI0SGYyYTNFMU0zZ2tEZUs5TUk5Q3pXOTZaUGt1MHlZ0gGoAUFVX3lxTE1qS1VZdE1uQVZrZl9YdmFGcVJDLVdpQ1VELXBVb3lfbzlPUU1iNGR0clp3eHpUN01HeEJSVEhldkZSOGxSV1EzcGpZQzFnRzBXeDFseldZT01aX1p1bGQyQ0Z0M09qZURjWHdFcXo0LWt6cUhDQTE4d3lqTjR5cldDWjhHRHhHT0NVR3lzeVRoTTltWk5Oa1BGckdSNjJRTjVqVWxUQ05oVw?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Pfizer and GSK in antidepressant safety probes', 'publisher': {'href': 'https://pharmafile.com', 'title': 'Pharmafile'}, 'created_at': 'Tue, 22 Sep 2015 07:00:00 GMT', 'description': 'Pfizer and GSK in antidepressant safety probes  Pharmafile', 'url': 'https://news.google.com/rss/articles/CBMifEFVX3lxTE1lY0pTamlXMVlQY3A5QUk5TU9saGJtX3pVWWFwNFk1amFUaW1JUTZEZEYtZW04OEtEY2k1U0hUSi1QdlFwaXlSS1F6Y3BiUmRQdUx0MVJsdEtiSmxwcHZvb05zUVRvZl9ncVN2UnZxOWdkUFBzYy0xZE8wSHQ?oc=5&hl=en-US&gl=US&ceid=US:en'}
